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Available online 14 June 2014A hairy root line of Edelweiss (Leontopodium nivale ssp. alpinum (Cass.) Greuter) was obtained
upon transformation with Agrobacterium rhizogenes strain ATCC15834. Elicitation of this line
with silver nitrate, sucrose, methyl jasmonate and yeast extract at various concentrations in
most cases resulted in a stimulation of lignan biosynthesis. Through elicitation with 6% sucrose
the roots accumulated the pharmacologically active lignans leoligin and 5-methoxy-leoligin at
levels of 0.0678% and 0.0372%, respectively, without significant growth inhibition. These lignan
levelswere comparable to those found in intact roots of cultivated Edelweiss. The biotechnological
production of leoligin could be an attractive option for the continuous, field culture-independent
production of the valuable secondary metabolites leoligin and 5-methoxy-leoligin.
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Elicitor1. Introduction
The genus Leontopodium (R.Br. ex Cassini) belongs to the
Asteraceae family and comprises about 30 species [1]. The
well-known alpine Edelweiss (Leontopodium nivale ssp.
alpinum (Cass.) Greuter or L. alpinum Cass.) is found in the
mountain regions of Europe, mostly in the Alps, Carpathians,
Pyrenees, the Tatra and the Balkan Peninsula [2]. Edelweiss
has been used in traditional medicine since centuries against
ailments like diarrhea, abdominal aches, bronchitis or fever
[3,4]. Recent studies revealed that extracts from aerial parts
and roots possess anti-inflammatory [5,6] and analgesic [6]
activities. Phytochemical research has revealed the occur-
rence of various secondary compounds like diterpenes [7],
sesquiterpenes [8,9], benzofuranoids [10] and lignans [7,10].; MS, nutrientmedium
ate; YE, yeast extract
x: +43 1 4277 9552.
(C. Wawrosch).
B.V. This is an open access arIn the latter class the metabolite, leoligin, has recently been
isolated [10]. This lariciresinol-type lignan (see Fig. 1) has
been shown to inhibit in vitro leukotriene biosynthesis and
intimal hyperplasia of venous bypass grafts, seemingly without
toxic side effects [11]. It inhibits in vivo neointima formation
without causing endothelial damage, and it is not thrombo-
genic [11]. Vein graft disease, i.e. the progressive degeneration
of veins used in surgical bypass operations, is characterized by
endothelial damage, smooth muscle cell proliferation and
pro-inflammatory signaling [11,12]. Drug eluting stents are
considered to be the most likely approach in the prevention of
graft failure, but currently there is a lack of drugs with specific
activity. Leoligin is considered to have a great potential for the
treatment of vein graft disease [11]. The structurally related
compound 5-methoxy-leoligin (see Fig. 1) has recently been
shown to be a very promising candidate for the development
of the first low molecular weight pro-angiogenic and pro-
arteriogenic drug for the treatment of myocardial infarction
[13]. Myocardial infarction is a major cause of mortality
worldwide. Recent treatment strategies in the therapy ofticle under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
Fig. 1. Structure of leoligin (R = H) and 5-methoxy-leoligin (R = OCH3).
220 C. Wawrosch et al. / Fitoterapia 97 (2014) 219–223myocardial infarction aim at the improvement of ventricular
function, among others by stimulating angiogenesis and
arteriogenesis, namely the induction of artery growth to
bypass occluded arteries [13]. In this, there is an urgent need
to find new drugs, and 5-methoxy-leoligin has shown to
possess corresponding pro-angiogenic and pro-arteriogenic
activities.
Edelweiss is a protected plant in many countries. While it
is cultivated in large quantities in Switzerland [14], the
isolation of relevant amounts from Edelweiss roots remains
a laborious task due to the low content [10,15] and the thin
and fibrous nature of the roots of cultivated plants [16].
As the chemical synthesis has not yet been described the
biotechnological production might be an alternative ap-
proach to the procurement of relevant amounts of these
lignans. Hairy root cultures, i.e. in vitro cultured roots which
result from the infection (transformation) of higher plants
with the soil-born bacterium Agrobacterium rhizogenes, have
been investigated for a few decades as biological systems for
the production of secondary compounds from medicinal
plants [17]. Hairy roots can in many cases produce the same
compounds found in normal roots of the parent plant, but
while in callus or cell suspension cultures this productivity
frequently diminishes over time it remains stable in
transformed roots [18]. Furthermore, in the recent past
hairy root technology has been significantly improved
concerning accumulation and excretion of secondary me-
tabolites after elicitation, and scale-up of the culture process
[17]. With regard to the production of lignans from hairy
roots a number of studies have focused on podophyllotoxin
and its derivatives, an important lead for anticancer drugs.
For example, hairy root lines of Linum album produced
105 μg/L [19] or 5.12 mg/L [20] of the lignan while a content
of 14.11 mg/L was measured in the roots of wild growing
plants [19]. In Linum flavum, hairy roots were reported to
contain up to 3.5% 5-methoxypodophyllotoxin [21] which is
comparable to the amount of 3.68% described for roots of
greenhouse grown plants [22]. Another arylnaphthalene
lignan, justicin B, is found in normal root cultures (12.5 mg/L)
and hairy root cultures (16.9 mg/L) of Linum austriacum[23].
Silymarin is a flavonolignan complex with hepatoprotectiveproperties isolated from the fruits of the milk thistle plant,
Silybum marianum. While hairy roots contained more isosilybin
A and B than untransformed root cultures, the content of four
other flavonolignans was higher in the latter culture type [24].
It has been demonstrated previously that L. nivale ssp.
alpinum can be transformed with A. rhizogenes, and resulting
hairy root lines were shown to produce anthocyanins, hy-
droxycinnamic acid esters, and essential oil [25]. In the
present study a hairy root clone of Edelweiss was investi-
gated specifically in respect of its leoligin and 5-methoxy-
leoligin content and the influence of the treatment with
elicitors, molecules that stimulate defense or stress-induced
responses in plants [26], on product formation.
2. Experimental
2.1. Plant material
Seeds of L. nivale ssp. alpinum were purchased from
Austrosaat AG (Vienna, Austria) and were surface sterilized
for 30 min with an aqueous NaOCl solution (3.4% active
chlorine). They were then aseptically germinated on mod-
ified semisolid half-strength Murashige and Skoog (MS)
medium [27] supplemented with 1% sucrose and 0.3% Gelrite®
(Carl Roth, Karlsruhe, Germany). Shoots of 4 weeks old
seedlings were subsequently transferred to modified semisolid
MSmediumwith 3% sucrose, 0.4 mg/L thiamine hydrochloride,
80 mg/L myo-inositol, 100 mg/L caseine hydrolysate, 0.7% agar
(Merck, Darmstadt, Germany), 0.55 μM 1-naphthaleneacetic
acid and 0.25 μM kinetin [28] for further multiplication. Every
4 weeks shoot clusters were divided into single shoots which
were transferred to fresh medium. All cultures were kept at
25 ± 1 °C under a 16 hour photoperiodwith a light intensity of
40 μM · m−2 · s−1 (Sylvania Gro-Lux® fluorescent tubes). A
number of seedlings of this seed batch were also potted into
gardening soil and grown to the flowering stage. Voucher
specimens and living plants are kept at the Department of
Pharmacognosy, University of Vienna.
Three normal root samples of cultivated L. nivale ssp.
alpinum plants were obtained from the Mediplant Swiss
Research Centre on Medicinal and Aromatic Plants, Conthey,
Switzerland (two samples) and from W. Faulhammer,
Innsbruck, Austria (one sample). Vouchers are stored at the
herbarium of the Institute of Pharmacy/Pharmacognosy,
University of Innsbruck.
2.2. Hairy root culture
A. rhizogenes strain ATCC15834 was grown in liquid YMB
medium [29]. The middle veins of leaves of in vitro grown
Edelweiss shoots were gently scratched with a scalpel dipped
in the bacterial suspension and the shoots where then
cultivated on modified semisolid half-strength MS medium
with 3% sucrose in the light. Single roots which emerged from
the wounded sites after 4 weeks in average were dissected
from the leaves and treated twice for 10 days each with
liquid modified MS medium containing 3% sucrose and
500 mg/L of the antibiotic, cefotaxim. Subsequently the
hairy roots were routinely transferred to liquid modified MS
medium with 3% sucrose every 4 weeks: An inoculum of ca.
0.5 g was transferred to 50 mL of medium in a 250 mL
Table 1
Final biomass (g dry wt.) and contents (% dry wt.) of leoligin and 5-methoxy-leoligin in hairy root clone K8A of Leontopodium nivale ssp. alpinum treated with
various elicitors.
Sample/treatment Final biomass⁎ (g dry wt.) Leoligin (w%)⁎⁎ 5-methoxy-leoligin (w%)⁎⁎
K8A control 0.62 ± 0.03ade 0.0062 ± 0.0021a 0.0049 ± 0.0014ab
15 μM AgNO3 0.44 ± 0.03bc 0.0321 ± 0.0094bc 0.0260 ± 0.0075e
30 μM AgNO3 0.43 ± 0.02bc 0.0183 ± 0.0021ab 0.0153 ± 0.0019bcd
60 μM AgNO3 0.36 ± 0.03b 0.0217 ± 0.0015ab 0.0177 ± 0.0014cde
5% Sucrose 0.64 ± 0.04ae 0.0142 ± 0.0032ab 0.0083 ± 0.0018abc
6% Sucrose 0.59 ± 0.03ade 0.0678 ± 0.0042d 0.0372 ± 0.0025f
7% Sucrose 0.70 ± 0.05a 0.0221 ± 0.0062ab 0.0101 ± 0.0027abcd
1 g/L YE 0.69 ± 0.04a 0.0192 ± 0.0054ab 0.0118 ± 0.0028abcd
2 g/L YE 0.61 ± 0.05ade 0.0337 ± 0.0094bc 0.0204 ± 0.0050de
5 g/L YE 0.59 ± 0.05ade 0.0035 ± 0.0016a 0.0019 ± 0.0008a
50 μM MeJa 0.50 ± 0.05cd 0.0316 ± 0.0097bc 0.0116 ± 0.0028abcd
100 μM MeJa 0.45 ± 0.05bc 0.0498 ± 0.0152cd 0.0188 ± 0.0050cde
200 μM MeJa 0.54 ± 0.04cde 0.0249 ± 0.0037ab 0.0098 ± 0.0013abcd
300 μM MeJa 0.59 ± 0.03ade 0.0173 ± 0.0035ab 0.0113 ± 0.0021abcd
⁎ Values are mean ± S.E. (n = 5) per culture flask with 50 mL nutrient medium after 4 weeks of culture; means followed by the same letter are not
significantly different (p = 0.05) according to Duncan's multiple range test.
⁎⁎ Values are mean ± S.E. (n = 2, each measured 3 times); means followed by the same letter are not significantly different (p = 0.05) according to Duncan's
multiple range test.
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rotary shaker at 100 RPM. The root line K8A was used for the
elicitation experiments.
2.3. Elicitor treatments
Elicitors were added to 3 weeks old hairy root cultures
except for the treatments with elevated sucrose concentra-
tions which occurred for the whole culture period. Silver
nitrate (Merck, Darmstadt, Germany, analytical grade) was
dissolved in distilled water and the filter sterilized (0.22 μm)
solution was added to hairy root cultures at final concentra-
tions of 15, 30 and 60 μMAgNO3, respectively. Similarly, filter
sterilized solutions of methyl jasmonate (MeJa; Sigma–
Aldrich, St. Louis, USA; 95% purity) in 96% ethanol were
added to achieve final concentrations of 50, 100, 200 and
300 μM. Yeast extract (YE; Sigma–Aldrich, St. Louis, USA) was
purified by dual precipitation with ethanol as described by
Hahn and Albersheim [30]. After autoclaving (20 min at
121 °C) of the resulting aqueous solution aliquots were
added to hairy root cultures at final concentrations of 1, 2
or 5 g/L. For osmotic treatment, hairy roots were inoculated
in liquid modified MS media supplemented with 5, 6 or 7%
sucrose. Root materials were always harvested after a total
cultivation period of 4 weeks and were dried at room
temperature.
2.4. HPLC-UV analysis
2.4.1. Sample preparation
A small amount of ground root sample was weighted
(100.0 mg). The plant material was sonicated with 20 mL of
dichloromethane for 10 min in the ultrasonic bath before
being filtrated over cotton wool. This manipulation was
repeated two times with 10 mL of dichloromethane each.
After evaporation of the solvent of the combined extracts at
reduced pressure the dry residue was dissolved in 1.00 mL of
methanol, again filtered over cotton wool and analyzed byHPLC-UV. The efficacy of the extraction protocol was proved
by a fourth extraction with 10 mL dichloromethane. The
extract was evaporated separately, dissolved in 1.00 mL
MeOH and analyzed by HPLC-UV. Since no signals of leoligin
and 5-methoxy-leoligin were found, extraction was found to
be exhaustive. Two extracts of each hairy root culture sample
were prepared. Both were analyzed three times, and the six
values of the peak area were used to perform the quantifi-
cation of leoligin and 5-methoxy-leoligin in the samples.
2.4.2. HPLC-UV method and quantiﬁcation parameters
An HP 1050 system (Agilent, Waldbronn, Germany)
equipped with auto sampler, DAD and column thermostat
was used. The stationary phase was a Phenomenex Kinetex
2.6 μ C18 100 A (100 mm × 2.1 mm) with 2.6 μm particles
equipped with the corresponding guard column. The tem-
perature was set to 40 °C. The mobile phase consisted of
two solvents: A = water, B = acetonitrile. The composition
during run was set as following: 0 min: 65% A, 35% B;
20 min: 50% A, 50% B; 25 min: 1% A, 99% B; stop: 35 min;
post time: 15 min. The flow rate was 0.250 mL/min and the
detection wavelength was 205 nm. As standard for quanti-
fication pure leoligin and 5-methoxy-leoligin were dissolved
in 1.00 mL of methanol and diluted to obtain five reference
solutions (73.1 μg/mL to 4.6 μg/mL; 54.4 μg/mL to 3.4 μg/mL),
which were analyzed to afford a calibration curve of y =
230818.83405x + 496.66528; R2 = 0.99819 for leoligin as
well as y = 190969.00754x − 47.98333; R2 = 0.9995219 for
5-methoxy-leoligin.
2.4.3. Chemicals and reagents
All solvents (dichloromethane, methanol and acetonitrile)
were of analytical grade (99.9%) provided from Merck
(Darmstadt, Germany). The used water was produced via
reverse-osmosis. Leoligin and 5-methoxy-leoligin had a
purity level higher than 98%, according to LC-DAD/MS and
NMR examination. These references were prepared at the
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Innsbruck [7].
3. Results and discussion
The hairy roots line K8A which was investigated in this
study was chosen due to its fast growth. When cultivated
under standard conditions, i.e. in liquid modified MS medium
with 3% sucrose, it yielded 0.0062% LG and 0.0049 MLG
(Table 1). In many cases, secondary metabolite accumulation
in hairy root cultures can be enhanced by elicitation, i.e.
treatment of the culture with biotic and abiotic elicitors [31].
We therefore treated our hairy root line with the two abiotic
elicitors silver nitrate and sucrose, and the two biotic
elicitors yeast extract and methyl jasmonate. As elicitation
can, despite an improved product yield, also result in
decrease of biomass accumulation [32], hairy root growth
was assessed in terms of final dry weight, too. Silver nitrate
at a concentration of 15 μM led to a ca. 5-fold increase of the
levels of both LG and MLG, but on the other hand root
growth was negatively influenced (about 30% less biomass).
Elicitation with 30 or 60 μM AgNO3 had a less pronounced
and not significant impact on lignan biosynthesis. Similarly,
enhanced production of silymarin in hairy root cultures of
S. marianum has also been achieved through the use of silver
nitrate [33]. A treatment with 30 or 60 μM of this elicitor
lowered the total phenolics content in hairy roots of Salvia
miltiorrhiza, but slightly stimulated the formation of these
metabolites at a concentration of 15 μM [31]. But, in the
same culture type Ge and Wu [34] found Ag+ to stimulate
the production of tanshinones, and silver nitrate significantly
increased the accumulation of the tropane alkaloids, scopol-
amine and hyoscyamine in hairy roots of Brugmansia candida
[35].
Beside its role as carbon source in in vitro cultures,
sucrose at elevated concentrations can act as abiotic elicitor
due to increased osmotic pressure. We therefore investigated
the effect of this sugar at concentrations of 5, 6 or 7%. While
lignan formation was not significantly enhanced when 5 or
7% sucrose was used, at 6% the content of LG and MLG
increased to 0.0678% and 0.0372%, respectively, which was
10.9-fold and 7.6-fold higher than that in the control roots
with the standard sucrose concentration of 3%. Hairy root
growth was not significantly impaired at any of the tested
sucrose concentrations. An elevated sucrose concentration of
6% also stimulated glycyrrhizin production in hairy roots of
Glycyrrhiza inflata[36]. In hairy roots of Withania somnifera,
accumulation of the steroidal lactone, withaferin A was
enhanced by treatment with 4% but not with 6% sucrose [37].
Plant cell suspension cultures of Melastoma malabathricum
produced more anthocyanins with 4.5–7.5% sucrose than
with 3% [38], and using 5% sucrose the formation of rosmarinic
acid in suspension cultures of Ocimum sanctumwas higher than
with 4 or 7% of the sugar [39].
Yeast extract (YE) and preparations thereof have been
widely used as elicitors in plant tissue culture [40]. When
purified YE [30] was added to cultures of the Edelweiss hairy
root clone K8A, 1 or 5 g/L did not significantly influence
neither lignan formation nor root growth. At a concentration
of 2 g/L a 5-fold (LG) and 4-fold (MLG) promotion of product
formation was observed, while biomass increase was notaffected. In cell cultures of S. miltiorrhiza 100 mg/L but not 50
or 200 mg/L YE led to the highest tanshinone yield [41]. In
hairy root cultures of the same plant species rosmarinic acid
formation was enhanced similarly irrespective of the con-
centration of YE elicitor, while cryptotanshinone biosynthesis
was improved in a dose dependent manner [42].
As a second biotic elicitor we chose methyl jasmonate
(MeJa) which has been shown to stimulate secondary
metabolite formation in awide variety of plant in vitro cultures.
In particular, the production of lignans was shown to rise in cell
suspension cultures of Forsythia x intermedia[43] and L. album
[44] upon treatment with MeJa. Elicitation of Edelweiss hairy
root clone K8A with 50 or 100 μMMeJa resulted in accumula-
tion of up to 0.0498% LG and 0.0188% MLG (8-fold and 3.8-fold
higher than in the control, respectively), although at 100 μM
MeJa root growth was significantly suppressed. Higher concen-
trations (200 or 300 μMMeJa) showed no influence on biomass
production but enhanced lignan formation only to a moderate
non significant extent.
The leoligin content of wild growing Edelweiss has been
described to account for 0.005–0.010% [15]. Within the
present study, analysis of two samples of cultivated L. nivale
ssp. alpinum from Switzerland (Mediplant Swiss Research
Centre on Medicinal and Aromatic Plants) revealed a content
of 0.0155 and 0.0547% LG and 0.1293 and 0.0672% MLG,
respectively. Another sample from field culture in Innsbruck,
Austria yielded 0.0632% LG and 0.0421% MLG. Although no
further data concerning the lignan content in Edelweiss are
available so far, a variability regarding both the content and
the ration of LG to MLG seem to be likely. Furthermore, it is
not clear whether the growing conditions (wild vs. controlled
cultivation) have an influence on lignan production. Anyhow,
the basic LG content of the hairy root clone K8A used in the
present study was found to be of the order of wild growing
Edelweiss [15]. Similarly, untransformed roots and hairy
roots of L. flavum accumulated comparable amounts of the
lignan, 5-methoxypodophyllotoxin [21,22]. As delineated
above, lignan contents in hairy roots have been described to
be higher, lower or equal to that in normal roots depending
on factors like e.g. plant genotype or Agrobacterium strain
used for transformation. The production of LG could be
significantly increased nearly 11-fold through elicitation with
6% sucrose. Similarly, the MLG content of clone K8A could be
enhanced 7.6-fold, and elicitation had no significant impact
on biomass accumulation.
4. Conclusions
Only recently the highly active lignan compounds
leoligin and 5-methoxy-leoligin have been isolated from
the roots of the alpine Edelweiss, casting new light on this
tradition-steeped plant. As an alternative to the laborious
extraction of the low amounts found in the plant, we could
show that a transformed hairy root line of Edelweiss
accumulates the valuable lignans in concentrations which,
upon elicitation with 6% sucrose, resembles the content in
normal roots. Analyses of three samples of normal roots
revealed a degree of variation in both total lignan content
and ratio of the two compounds. Future work will therefore
focus on the establishment of further hairy root clones
starting from high yielding Edelweiss genotypes, and using
223C. Wawrosch et al. / Fitoterapia 97 (2014) 219–223additional A. rhizogenes strains. In any case, as a continuous,
sustainable and renewable production system independent of
climatic or environmental effects [45] the biotechnological
production of leoligin and 5-methoxy-leoligin would be of
advantage over the extraction from field grown plants.
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